Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sedative-hypnotic tolerance testing and withdrawal comparing diazepam to barbiturates

P J Perry, R L Stambaugh, M T Tsuang

    Journal of Clinical Psychopharmacology
    |September 1, 1981
    PubMed
    Summary

    Diazepam can be substituted for pentobarbital and phenobarbital in sedative-hypnotic tolerance testing and withdrawal. This study found diazepam effective in preventing abstinence symptoms during withdrawal from sedative-hypnotics.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

    Schizophrenia research·2020
    Same author

    Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

    Development and psychopathology·2020
    Same author

    Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

    Schizophrenia research·2018
    Same author

    Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.

    Genes, brain, and behavior·2017
    Same author

    Genetics of Schizophrenia: Historical Insights and Prevailing Evidence.

    Advances in genetics·2016
    Same author

    An 11-year retrospective review of venlafaxine ingestion in children from the California Poison Control System.

    Human & experimental toxicology·2015

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Neuroscience

    Background:

    • Sedative-hypnotic medications like pentobarbital and phenobarbital are commonly used.
    • Tolerance and dependence can develop with long-term use, necessitating careful withdrawal protocols.
    • Diazepam, a benzodiazepine, is an alternative with a different pharmacological profile.

    Purpose of the Study:

    • To evaluate the feasibility of using diazepam for sedative-hypnotic tolerance testing.
    • To assess diazepam's efficacy in the withdrawal management of patients tolerant to sedative-hypnotics.
    • To compare diazepam's withdrawal effects against traditional barbiturates.

    Main Methods:

    • Nineteen patients with potential sedative-hypnotic dependence underwent tolerance testing with either diazepam or pentobarbital.

    Related Experiment Videos

  • Tolerant patients were subsequently withdrawn using either diazepam or phenobarbital, respectively.
  • Comparison data from 78 previously studied subjects with similar drug dependencies were utilized.

    • Main Results:

    • Successful withdrawal was achieved in all participating patients.
    • No significant differences were observed in the incidence of seizures or delirium between the barbiturate and diazepam groups.
    • A significant difference was noted between observed and expected minor withdrawal symptoms in the diazepam-treated group.

    Conclusions:

    • Diazepam appears feasible for sedative-hypnotic tolerance testing and withdrawal.
    • Diazepam may be effective in preventing severe abstinence symptoms like seizures and delirium.
    • Further research is needed to fully understand the nuances of minor withdrawal symptom management with diazepam.